Mind This Psychedelic Medicine Stock

Mental health issues are on the rise – and so is demand for treatments for mental health disorders based on psychedelic substances. As a result, the psychedelic medicine biotech company with a pipeline of innovative treatments discussed in today’s article is attracting investors’ attention. But is the stock a good buy right now? For a look at the factors that could shape its performance in the near term, CLICK HERE.